Transfusion of RhD-positive blood in "Asia type" DEL recipients

New England Journal of Medicine

Volumn 362, Issue 5, 2010, Pages 472-473

  Shao, Chao Peng ^a  

^a Shenzhen Blood Center   (China)

Author keywords

[No Author keywords available]

Indexed keywords

RHESUS ANTIBODY; RHESUS D ANTIGEN;

ADULT; ALLOIMMUNIZATION; ANTIBODY DETECTION; ASIA; BLOOD GROUP RHESUS SYSTEM; BLOOD TRANSFUSION; CONTROLLED STUDY; ERYTHROCYTE TRANSFUSION; FEMALE; GENE EXPRESSION; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; IMMUNOGENICITY; LETTER; MAJOR CLINICAL STUDY; PHENOTYPE; POLYMERASE CHAIN REACTION; PREGNANCY; PRIORITY JOURNAL; PROSPECTIVE STUDY;

EID: 76149127039     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc0909552     Document Type: Letter

References (5)

1. Chen JC, Lin TM, Chen YL, Wang YH, Jin YT, Yue CT. RHD 1227A is an important genetic marker for RhD(el) individuals. Am J Clin Pathol 2004;122:193-8.
2. Shao CP, Maas JH, Su YQ, Köhler M, Legler TJ. Molecular background of Rh D-positive, D-negative, D(el) and weak D phenotypes in Chinese. Vox Sang 2002;83:156-61.
3. Legler TJ, Maas JH, Köhler M, et al. RHD sequencing: a new tool for decision making on transfusion therapy and provision of Rh prophylaxis. Transfus Med 2001;11:383-8.
4. Körmöczi GF, Gassner C, Shao CP, Uchikawa M, Legler TJ. A comprehensive analysis of DEL types: partial DEL individuals are prone to anti-D alloimmunization. Transfusion 2005;45:1561-7.
5. Denomme GA, Flegel WA. Applying molecular immunohematology discoveries to standards of practice in blood banks: now is the time. Transfusion 2008;48:2461-75.